Invention Grant
- Patent Title: Compounds for the treatment of Clostridium difficile associated disease
- Patent Title (中): 用于治疗艰难梭菌相关疾病的化合物
-
Application No.: US14620902Application Date: 2015-02-12
-
Publication No.: US09278091B2Publication Date: 2016-03-08
- Inventor: Peter David Johnson , Richard John Vickers , Francis Xavier Wilson , Colin Richard Dorgan , Lauren Jayne Sudlow , Stephen Paul Wren , Renate Maria van Well
- Applicant: Summit Therapeutics PLC
- Applicant Address: GB Abingdon, Oxfordshire
- Assignee: Summit Therapeutics PLC
- Current Assignee: Summit Therapeutics PLC
- Current Assignee Address: GB Abingdon, Oxfordshire
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: GB1009097.5 20100601; GB1106981.2 20110427
- Main IPC: C07D403/04
- IPC: C07D403/04 ; A61K31/4164 ; A61K31/444 ; A61K31/424 ; A61K31/546 ; A61K35/741 ; A61K38/14 ; A61K45/06 ; C07D401/04 ; C07D405/14 ; C07D409/14 ; C07D471/04 ; C07D495/04 ; C07D401/14 ; A61K31/4439 ; C07D403/14 ; C07D417/14 ; A61K31/4365 ; A61K31/437 ; A61K31/74 ; A61K35/747 ; A61K36/064 ; A61K39/395
Abstract:
Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.
Public/Granted literature
- US20150209340A1 COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE Public/Granted day:2015-07-30
Information query
